Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial plan...
A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll clinical...
FN Media Group Presents Microsmallcap.com Market Commentary  New York, NY – October 5, 2022 – A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease,...
/PRNewswire/ -- A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer's disease, announcing recently that it has gotten...
Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) is a Canadian company that makes natural, scalable, and easy-to-get psychedelic and functional mushrooms, as well as synthetic formulations, to help people...
FN Media Group Presents Microsmallcap.com Market Commentary  New York, NY – September 7, 2022 – According to a new survey by Johns Hopkins Medicine researchers, people’s attitudes toward death...
/PRNewswire/ -- According to a new survey by Johns Hopkins Medicine researchers, people's attitudes toward death change after a psychedelic drug experience and...
FN Media Group Presents Microsmallcap.com Market Commentary  New York, NY – September 1, 2022 – Young adults are using more hallucinogens than ever. According to a National Institute of Health...
/PRNewswire/ -- Young adults are using more hallucinogens than ever. According to a National Institute of Health survey, the amount of people between age 19 to...
Blue Serenity brings science and compassion together, will cement Thomas Hartle’s legacy as a Canadian psychedelic icon Optimi and...